Kelly S Klega (Kelly Klega)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Chronic Lymphocytic Leukemia

Loop Mediated Isothermal Amplification

Palliative Care

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Wallace Bourgeois, Jevon A Cutler, Brandon J Aubrey, Daniela V Wenge, Florian Perner, Cynthia Martucci, Jill A Henrich, Kelly S Klega, Radosław P Nowak, Katherine Aleisha Donovan, Meaghan Boileau, Yanhe Wen, Charles Hatton, Athina A Apazidis, Sarah Naomi Olsen, Nadia Kirmani, Yana Pikman, Jessica A Pollard, Jennifer A Perry, Adam S Sperling, Benjamin L Ebert, Gerard M McGeehan, Brian D Crompton, Eric S Fischer, Scott A Armstrong
Mezigdomide is effective alone and in combination with Menin inhibition in pre-clinical models of KMT2A-r and NPM1c AML. Blood (2023)
Samuel Abbou, Kelly S Klega, Junko Tsuji, Mohammad Tanhaemami, David C Hall, Donald A Barkauskas, Mark D Krailo, Carrie Cibulskis, Anwesha Nag, Aaron R Thorner, Samuel Pollock, Alma Imamovic, Jack F Shern, Steven G DuBois, Rajkumar Venkatramani, Douglas S Hawkins, Brian D Crompton
Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Peter Meade Anderson, Maurizio Ghisoli, Brian D Crompton, Kelly S Klega, Leonard H Wexler, Emily K Slotkin, Laura Stanbery, Luisa Manning, Gladice Wallraven, Meghan Manley, Staci Horvath, Ernest Bognar, John J Nemunaitis
Pilot Study of recurrent Ewing's Sarcoma management with Vigil/Temozolomide/Irinotecan and assessment of circulating tumor (ct) DNA. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Samuel Abbou, Kelly S Klega, Junko Tsuji, Mohammad Tanhaemami, David C Hall, Donald A Barkauskas, Mark D Krailo, Carrie Cibulskis, Anwesha Nag, Aaron R Thorner, Samuel Pollock, Alma Imamovic, Jack F Shern, Steven G DuBois, Rajkumar Venkatramani, Douglas S Hawkins, Brian D Crompton
Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Laura-Maria Madanat-Harjuoja, Lindsay A Renfro, Kelly S Klega, Brett Tornwall, Aaron R Thorner, Anwesha Nag, David Dix, Jeffrey S Dome, Lisa R Diller, Conrad V Fernandez, Elizabeth A Mullen, Brian D Crompton
Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (26) (2022)
Matthew L Hemming, Patrick Bhola, Michael A Loycano, Justin A Anderson, Madeleine L Taddei, Leona A Doyle, Elizaveta Lavrova, Jessica L Andersen, Kelly S Klega, Morgan R Benson, Brian D Crompton, Chandrajit P Raut, Suzanne George, Anthony G Letai, George D Demetri, Ewa Sicinska
Preclinical Modeling of Leiomyosarcoma Identifies Susceptibility to Transcriptional CDK Inhibitors through Antagonism of E2F-Driven Oncogenic Gene Expression. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (11) (2022)